In the month of the Nobel Prize Awards, we pay tribute to Alfred Nobel and to the recipients of the 2018 Prize in Physiology and Medicine
DOI:
https://doi.org/10.19230/jonnpr.2777Keywords:
-Abstract
-Downloads
References
Sánchez-Muniz FJ, Culebras JM, Vacas LV. In the month of the Nobel Prize Awards, we pay tribute to Alfred Nobel and to the recipients of the 2017 Prize in Physiology and Medicine. JONNPR 2017; 2(11): 577-580.
Rincón del vago https://www.rincondelvago.com/informacion/premios- nobel/
Sánchez-Muniz FJ, Simón Martín C. Clock genes, chronodisruption, nutrition and obesity. Current Research in Diabetes & Obesity Journal 2017; 3(2)CRDJ. MS.ID. 555607.
Simón Martin C, Sánchez-Muniz FJ. Cronodisrupción y desequilibrio entre cortisol y melatonina ¿Una antesala probable de las patologías crónicas degenerativas más prevalentes? JONNPR, 2017; 2(11): 619-633.
Premio Nobel de Medicina 2011: Página Oficial. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/
Geffner J, Rabinovich GA. [Nobel Prizes 2011: dendritic cells, toll-like receptors and their contribution to fundamental and translational medicine]. Rev Fac Cien Med Univ Nac Cordoba.
NobelPrize.org. Nobel Media AB 2018. Wed. 3 Oct 2018. https://www.nobelprize.org/prizes/medicine/2018/press-release/
Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996; 271(5256): 1734–1736.
Kwon E D, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sci USA. 1997; 94(15): 8099–8103.
Liu D, Jenkins RW, Sullivan RJ. Mechanisms of resistance to immune checkpoint blockade. Am J Clin Dermatol. 2018. Sep 26. doi: 10.1007/s40257-018-0389-y.
Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A, Padera R, Jaklitsch MT, Shanka S, Chen TC, Korman A, Allison JP, Dranoff G. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA. 2003; 100(8): 4712-4717.
Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11(11): 3887–3895.
Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of Lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151.
Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H. Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000; 192(7): 1027–1034.
Iwai Y, Terawaki S, Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol. 2005; 17(2): 133–144.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License